TDAM USA’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $25.6M | Buy |
333,932
+27,087
| +9% | +$2.16M | 1.59% | 11 |
|
|
2021
Q3 | $23M | Sell |
306,845
-2,535
| -0.8% | -$193K | 1.52% | 12 |
|
|
2021
Q2 | $23.8M | Sell |
309,380
-26,211
| -8% | -$1.95M | 1.47% | 11 |
|
|
2021
Q1 | $24.7M | Sell |
335,591
-1,994
| -0.6% | -$147K | 1.5% | 12 |
|
|
2020
Q4 | $26.4M | Sell |
337,585
-17,690
| -5% | -$1.35M | 1.65% | 9 |
|
|
2020
Q3 | $28.1M | Sell |
355,275
-369
| -0.1% | -$28.9K | 1.94% | 8 |
|
|
2020
Q2 | $25.8M | Buy |
355,644
+94,425
| +36% | +$7.11M | 1.87% | 9 |
|
|
2020
Q1 | $19.2M | Buy |
261,219
+30,399
| +13% | +$2.39M | 1.61% | 12 |
|
|
2019
Q4 | $20M | Buy |
230,820
+2,470
| +1% | +$203K | 1.3% | 16 |
|
|
2019
Q3 | $18.3M | Buy |
228,350
+7,213
| +3% | +$578K | 1.3% | 14 |
|
|
2019
Q2 | $17.7M | Buy |
221,137
+2,679
| +1% | +$205K | 1.24% | 21 |
|
|
2019
Q1 | $17.3M | Buy |
218,458
+4,686
| +2% | +$350K | 1.23% | 21 |
|
|
2018
Q4 | $15.6M | Buy |
213,772
+69,254
| +48% | +$4.89M | 1.13% | 24 |
|
|
2018
Q3 | $9.29M | Sell |
144,518
-110
| -0.1% | -$7.01K | 0.56% | 54 |
|
|
2018
Q2 | $8.38M | Sell |
144,628
-4,899
| -3% | -$276K | 0.53% | 60 |
|
|
2018
Q1 | $7.77M | Sell |
149,527
-11,794
| -7% | -$637K | 0.47% | 71 |
|
|
2017
Q4 | $8.66M | Sell |
161,321
-2,904
| -2% | -$161K | 0.5% | 65 |
|
|
2017
Q3 | $10M | Sell |
164,225
-11,130
| -6% | -$675K | 0.59% | 57 |
|
|
2017
Q2 | $10.8M | Sell |
175,355
-23,787
| -12% | -$1.45M | 0.55% | 62 |
|
|
2017
Q1 | $12.1M | Buy |
199,142
+17,215
| +9% | +$1.04M | 0.61% | 59 |
|
|
2016
Q4 | $10.2M | Sell |
181,927
-20,725
| -10% | -$1.21M | 0.54% | 66 |
|
|
2016
Q3 | $12.1M | Sell |
202,652
-7,500
| -4% | -$439K | 0.6% | 55 |
|
|
2016
Q2 | $11.6M | Sell |
210,152
-5,888
| -3% | -$313K | 0.57% | 60 |
|
|
2016
Q1 | $10.9M | Sell |
216,040
-5,126
| -2% | -$251K | 0.53% | 63 |
|
|
2015
Q4 | $11.1M | Sell |
221,166
-17,725
| -7% | -$894K | 0.54% | 67 |
|
|
2015
Q3 | $11.3M | Sell |
238,891
-18,738
| -7% | -$995K | 0.57% | 60 |
|
|
2015
Q2 | $14M | Sell |
257,629
-51,430
| -17% | -$2.88M | 0.63% | 55 |
|
|
2015
Q1 | $17M | Sell |
309,059
-14,764
| -5% | -$836K | 0.69% | 50 |
|
|
2014
Q4 | $17.5M | Sell |
323,823
-10,409
| -3% | -$580K | 0.74% | 48 |
|
|
2014
Q3 | $18.9M | Sell |
334,232
-29,941
| -8% | -$1.68M | 0.82% | 43 |
|
|
2014
Q2 | $20.1M | Sell |
364,173
-28,505
| -7% | -$1.56M | 0.85% | 36 |
|
|
2014
Q1 | $21.3M | Sell |
392,678
-312,640
| -44% | -$16.2M | 0.92% | 30 |
|
|
2013
Q4 | $33.7M | Sell |
705,318
-199,735
| -22% | -$9.13M | 1.45% | 12 |
|
|
2013
Q3 | $41.1M | Sell |
905,053
-24,533
| -3% | -$1.12M | 1.94% | 8 |
|
|
2013
Q2 | $41.4M | Buy |
+929,586
| New | +$41.5M | 1.89% | 10 |
|
Other funds holding MRK
TDAM USA's MRK Position: Q4 2021 in Review
TDAM USA increased its Merck (MRK) stake by 8.8% in Q4 2021, buying an estimated $2.16M and bringing the position to 333,932 shares worth $25.6M. The position accounts for 1.59% of the portfolio, ranked #11.
TDAM USA first reported a position in MRK in Q2 2013 and has held it in 35 quarters since. The position peaked at $41.4M in Q2 2013. 2,903 funds tracked by Wall St. Rank hold MRK as of Q4 2021.
- TDAM USA held 333,932 shares of Merck worth $25.6M as of Q4 2021.
- TDAM USA bought 27,087 Merck shares in Q4 2021, an estimated $2.16M.
- Merck made up 1.59% of TDAM USA's portfolio in Q4 2021, its #11 holding.
- TDAM USA first reported a position in Merck in Q2 2013 and has held it in 35 quarters since.
- TDAM USA's Merck position peaked at $41.4M in Q2 2013.
- 2,903 funds tracked by Wall St. Rank held Merck as of Q4 2021.
Based on TDAM USA's 13F filing for Q4 2021, filed 10 Feb 2022.